echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > The joint team of Zhu Di, Fudan University School of Basic Medicine, and Xu Jianmin, Affiliated Zhongshan Hospital, revealed the mechanism of colon cancer liver metastasis

    The joint team of Zhu Di, Fudan University School of Basic Medicine, and Xu Jianmin, Affiliated Zhongshan Hospital, revealed the mechanism of colon cancer liver metastasis

    • Last Update: 2022-09-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com



    On August 30, 2022, the team of Zhu Di of the School of Basic Medicine of Fudan University and the team of Xu Jianmin of Zhongshan Hospital Affiliated to Fudan University published a research paper entitled Tumor-infiltrated activated B cells suppress liver metastasis of colorectal cancers in Cell Reports


    Liver metastasis is one of the most important reasons affecting the prognosis of colon cancer, and its incidence and mortality are high


    Recent studies have shown that the tumor immune microenvironment plays an important role in the progression of cancer


    The authors first detected and compared the immune microenvironment composition of the primary tumor of colon cancer patients with liver metastases and non-metastatic patients by single-cell sequencing, and found that B cells and their subgroups of activated B cells in the primary tumor samples of colon cancer patients with liver metastases were significantly decrease


    By analyzing the differentiation trajectory of B cells, the authors found that B cell differentiation is closely related to liver metastasis


    Through further analysis, the authors identified a group of cells associated with the differentiation of activated B cells into plasma cells


    The authors constructed a mouse liver metastasis model and demonstrated that activated B cells can significantly inhibit liver metastasis



    Figure 1.


    In conclusion, this study revealed that activated B cells were significantly reduced in the primary tumor of colon cancer liver metastases by single-cell sequencing technology, and for the first time discovered a new type of B cells associated with left and right colon cancer heterogeneity and colon cancer liver metastasis.


    Zhu Di from the School of Basic Medicine of Fudan University, and Professor Xu Jianmin from Zhongshan Hospital Affiliated to Fudan University are the co-corresponding authors of this article



    Reference: Xu et al.


    The corresponding author and lead contact of this article, Zhu Di, is a national young special expert, dedicated to tumor immunopharmacology research.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.